tert-butyl beta-carboline-3-carboxylate has been researched along with Drug Withdrawal Symptoms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cook, JM; Divljaković, J; Milić, M; Namjoshi, OA; Savić, MM; Timić, T; Tiruveedhula, VV | 1 |
1 other study(ies) available for tert-butyl beta-carboline-3-carboxylate and Drug Withdrawal Symptoms
Article | Year |
---|---|
βCCT, an antagonist selective for α(1)GABA(A) receptors, reverses diazepam withdrawal-induced anxiety in rats.
Topics: Animals; Anxiety; Carbolines; Diazepam; Flumazenil; GABA-A Receptor Antagonists; Hypnotics and Sedatives; Male; Maze Learning; Rats; Rats, Wistar; Receptors, GABA-A; Substance Withdrawal Syndrome | 2013 |